Osaic Holdings
CRL icon

Osaic Holdings’s Charles River Laboratories CRL Stock Holding History

Osaic Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
2,286
+68
+3% +$12.1K ﹤0.01% 3642
2026
Q1 		$383K Sell
2,218
-48
-2% -$8.9K ﹤0.01% 3610
2025
Q4 		$452K Sell
2,266
-540
-19% -$98K ﹤0.01% 3424
2025
Q3 		$441K Buy
2,806
+1,715
+157% +$272K ﹤0.01% 3529
2025
Q2 		$165K Buy
1,091
+216
+25% +$28.8K ﹤0.01% 4102
2025
Q1 		$132K Sell
875
-2,573
-75% -$431K ﹤0.01% 3972
2024
Q4 		$637K Sell
3,448
-1,787
-34% -$344K ﹤0.01% 2568
2024
Q3 		$1.03M Sell
5,235
-682
-12% -$142K ﹤0.01% 2220
2024
Q2 		$1.22M Buy
5,917
+445
+8% +$101K ﹤0.01% 2030
2024
Q1 		$1.48M Sell
5,472
-17,365
-76% -$4.15M ﹤0.01% 1942
2023
Q4 		$5.4M Sell
22,837
-12,882
-36% -$2.53M 0.01% 1148
2023
Q3 		$7M Buy
35,719
+11,246
+46% +$2.31M 0.01% 1076
2023
Q2 		$5.15M Sell
24,473
-2,439
-9% -$485K 0.01% 1161
2023
Q1 		$5.43M Sell
26,912
-241
-0.9% -$54.6K 0.01% 1097
2022
Q4 		$5.92M Sell
27,153
-1,240
-4% -$271K 0.01% 996
2022
Q3 		$5.59M Sell
28,393
-6,720
-19% -$1.45M 0.01% 952
2022
Q2 		$7.51M Sell
35,113
-3,369
-9% -$823K 0.02% 821
2022
Q1 		$14.2M Sell
38,482
-3,900
-9% -$1.2M 0.03% 580
2021
Q4 		$16M Buy
42,382
+12,650
+43% +$4.91M 0.03% 508
2021
Q3 		$12.3M Buy
29,732
+5,735
+24% +$2.38M 0.03% 584
2021
Q2 		$8.88M Buy
23,997
+4,796
+25% +$1.6M 0.02% 704
2021
Q1 		$5.57M Buy
19,201
+1,729
+10% +$481K 0.01% 898
2020
Q4 		$4.36M Buy
17,472
+2,208
+14% +$526K 0.01% 935
2020
Q3 		$3.4M Buy
15,264
+1,590
+12% +$330K 0.01% 979
2020
Q2 		$2.39M Buy
13,674
+1,894
+16% +$302K 0.01% 1150
2020
Q1 		$1.49M Buy
+11,780
New +$1.77M 0.01% 1256

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Osaic Holdings's CRL Position: Q2 2026 in Review

Osaic Holdings increased its Charles River Laboratories (CRL) stake by 3.1% in Q2 2026, buying an estimated $12.1K and bringing the position to 2,286 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #3642.

Osaic Holdings first reported a position in CRL in Q1 2020 and has held it in 26 quarters since. The position peaked at $16M in Q4 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Osaic Holdings held 2,286 shares of Charles River Laboratories worth $518K as of Q2 2026.
  • Osaic Holdings bought 68 Charles River Laboratories shares in Q2 2026, an estimated $12.1K.
  • Charles River Laboratories made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3642 holding.
  • Osaic Holdings first reported a position in Charles River Laboratories in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Charles River Laboratories position peaked at $16M in Q4 2021.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.